These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

636 related articles for article (PubMed ID: 23182881)

  • 1. Impaired cerebral glucose metabolism in prodromal Alzheimer's disease differs by regional intensity normalization.
    Küntzelmann A; Guenther T; Haberkorn U; Essig M; Giesel F; Henze R; Schroeter ML; Schröder J; Schönknecht P
    Neurosci Lett; 2013 Feb; 534():12-7. PubMed ID: 23182881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease.
    Hunt A; Schönknecht P; Henze M; Seidl U; Haberkorn U; Schröder J
    Psychiatry Res; 2007 Jul; 155(2):147-54. PubMed ID: 17524628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statistical image analysis of cerebral glucose metabolism in patients with cognitive impairment following diffuse traumatic brain injury.
    Kato T; Nakayama N; Yasokawa Y; Okumura A; Shinoda J; Iwama T
    J Neurotrauma; 2007 Jun; 24(6):919-26. PubMed ID: 17600509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two distinct pathological substrates associated with MMSE-pentagons item deficit in DLB and AD.
    Beretta L; Caminiti SP; Santangelo R; Magnani G; Ferrari-Pellegrini F; Caffarra P; Perani D
    Neuropsychologia; 2019 Oct; 133():107174. PubMed ID: 31446008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral metabolic correlates of the clinical dementia rating scale in mild cognitive impairment.
    Perneczky R; Hartmann J; Grimmer T; Drzezga A; Kurz A
    J Geriatr Psychiatry Neurol; 2007 Jun; 20(2):84-8. PubMed ID: 17548777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.
    Ossenkoppele R; Zwan MD; Tolboom N; van Assema DM; Adriaanse SF; Kloet RW; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN
    Brain; 2012 Jul; 135(Pt 7):2115-25. PubMed ID: 22556189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies.
    Dukart J; Mueller K; Horstmann A; Vogt B; Frisch S; Barthel H; Becker G; Möller HE; Villringer A; Sabri O; Schroeter ML
    Neuroimage; 2010 Jan; 49(2):1490-5. PubMed ID: 19770055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Choice of reference area in studies of Alzheimer's disease using positron emission tomography with fluorodeoxyglucose-F18.
    Yakushev I; Landvogt C; Buchholz HG; Fellgiebel A; Hammers A; Scheurich A; Schmidtmann I; Gerhard A; Schreckenberger M; Bartenstein P
    Psychiatry Res; 2008 Nov; 164(2):143-53. PubMed ID: 18930634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precuneus and Cingulate Cortex Atrophy and Hypometabolism in Patients with Alzheimer's Disease and Mild Cognitive Impairment: MRI and (18)F-FDG PET Quantitative Analysis Using FreeSurfer.
    Bailly M; Destrieux C; Hommet C; Mondon K; Cottier JP; Beaufils E; Vierron E; Vercouillie J; Ibazizene M; Voisin T; Payoux P; Barré L; Camus V; Guilloteau D; Ribeiro MJ
    Biomed Res Int; 2015; 2015():583931. PubMed ID: 26346648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral glucose metabolism in preclinical and prodromal Alzheimer's disease.
    Herholz K
    Expert Rev Neurother; 2010 Nov; 10(11):1667-73. PubMed ID: 20977325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased cortical glucose metabolism in converters from CDR 0.5 to Alzheimer's disease in a community: the Osaki-Tajiri Project.
    Ishii H; Ishikawa H; Meguro K; Tashiro M; Yamaguchi S
    Int Psychogeriatr; 2009 Feb; 21(1):148-56. PubMed ID: 19040787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The comparison of the regional cerebral metabolism rate of glucose in Alzheimer's disease with mild cognitive impairment].
    Cao Q; Jiang K; Liu Y; Zhang M; Xiao S; Zuo C; Huang H
    Zhonghua Yi Xue Za Zhi; 2002 Dec; 82(23):1613-6. PubMed ID: 12667368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral glucose metabolism in patients with frontotemporal dementia.
    Ishii K; Sakamoto S; Sasaki M; Kitagaki H; Yamaji S; Hashimoto M; Imamura T; Shimomura T; Hirono N; Mori E
    J Nucl Med; 1998 Nov; 39(11):1875-8. PubMed ID: 9829574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.
    Mosconi L
    Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):486-510. PubMed ID: 15747152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concordance between (99m)Tc-ECD SPECT and 18F-FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA-AA criteria.
    Ito K; Shimano Y; Imabayashi E; Nakata Y; Omachi Y; Sato N; Arima K; Matsuda H
    Int J Geriatr Psychiatry; 2014 Oct; 29(10):1079-86. PubMed ID: 24687634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individual cerebral metabolic deficits in Alzheimer's disease and amnestic mild cognitive impairment: an FDG PET study.
    Del Sole A; Clerici F; Chiti A; Lecchi M; Mariani C; Maggiore L; Mosconi L; Lucignani G
    Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1357-66. PubMed ID: 18418593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18FDG PET in vascular dementia: differentiation from Alzheimer's disease using voxel-based multivariate analysis.
    Kerrouche N; Herholz K; Mielke R; Holthoff V; Baron JC
    J Cereb Blood Flow Metab; 2006 Sep; 26(9):1213-21. PubMed ID: 16525414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve.
    Cohen AD; Price JC; Weissfeld LA; James J; Rosario BL; Bi W; Nebes RD; Saxton JA; Snitz BE; Aizenstein HA; Wolk DA; Dekosky ST; Mathis CA; Klunk WE
    J Neurosci; 2009 Nov; 29(47):14770-8. PubMed ID: 19940172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease.
    Croteau E; Castellano CA; Fortier M; Bocti C; Fulop T; Paquet N; Cunnane SC
    Exp Gerontol; 2018 Jul; 107():18-26. PubMed ID: 28709938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advantage of late scanning in brain 18F-FDG PET.
    Ishii K
    J Nucl Med; 2006 Apr; 47(4):729; author reply 729. PubMed ID: 16595511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 32.